메뉴 건너뛰기




Volumn 42, Issue 1, 2012, Pages 33-41

Pegylated interferon α-2b plus ribavirin for Japanese chronic hepatitis C patients with normal alanine aminotransferase

Author keywords

Hepatitis C virus; Normal alanine aminotransferase; Pegylated interferon; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2B; RIBAVIRIN;

EID: 84055193435     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00907.x     Document Type: Article
Times cited : (5)

References (35)
  • 1
    • 0034129540 scopus 로고    scopus 로고
    • A relationship between the evaluation of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients
    • Hayashi J, Furusyo N, Ariyama I, Sawayama Y, Etoh Y, Kashiwagi S. A relationship between the evaluation of hepatitis C virus variants, liver damage, and hepatocellular carcinoma in patients. J Infect Dis 2000; 181: 1523-7.
    • (2000) J Infect Dis , vol.181 , pp. 1523-1527
    • Hayashi, J.1    Furusyo, N.2    Ariyama, I.3    Sawayama, Y.4    Etoh, Y.5    Kashiwagi, S.6
  • 2
    • 0027984424 scopus 로고
    • A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C
    • Hayashi J, Ohmiya M, Kishihara Y etal. A statistical analysis of predictive factors of response to human lymphoblastoid interferon in patients with chronic hepatitis C. Am J Gastroenterol 1994; 89: 2151-6.
    • (1994) Am J Gastroenterol , vol.89 , pp. 2151-2156
    • Hayashi, J.1    Ohmiya, M.2    Kishihara, Y.3
  • 3
    • 0032987514 scopus 로고    scopus 로고
    • Differences between interferon-alpha and-beta treatment for patients with chronic hepatitis C virus infection
    • Furusyo N, Hayashi J, Ohmiya M etal. Differences between interferon-alpha and-beta treatment for patients with chronic hepatitis C virus infection. Dig Dis Sci 1999; 44: 608-17.
    • (1999) Dig Dis Sci , vol.44 , pp. 608-617
    • Furusyo, N.1    Hayashi, J.2    Ohmiya, M.3
  • 4
    • 0031409685 scopus 로고    scopus 로고
    • Human lymphoblastoid interferon treatment for patients with hepatitis C virus-related cirrhosis
    • Furusyo N, Hayashi J, Ueno K etal. Human lymphoblastoid interferon treatment for patients with hepatitis C virus-related cirrhosis. Clin Ther 1997; 19: 1352-67.
    • (1997) Clin Ther , vol.19 , pp. 1352-1367
    • Furusyo, N.1    Hayashi, J.2    Ueno, K.3
  • 5
    • 0346732969 scopus 로고    scopus 로고
    • A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development
    • Kashiwagi K, Furusyo N, Kubo N etal. A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development. J Infect Chemother 2003; 9: 333-40.
    • (2003) J Infect Chemother , vol.9 , pp. 333-340
    • Kashiwagi, K.1    Furusyo, N.2    Kubo, N.3
  • 6
    • 0031043398 scopus 로고    scopus 로고
    • Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C viral infection
    • Hayashi J, Kishihara Y, Yamaji K etal. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C viral infection. Hepatology 1997; 25: 697-701.
    • (1997) Hepatology , vol.25 , pp. 697-701
    • Hayashi, J.1    Kishihara, Y.2    Yamaji, K.3
  • 7
    • 33646121757 scopus 로고    scopus 로고
    • Chronic hepatitis C in patients with persistently normal alanine transaminase levels
    • Shiffman ML, Diago M, Tran A etal. Chronic hepatitis C in patients with persistently normal alanine transaminase levels. Clin Gastroenterol Hepatol 2006; 4: 645-52.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , pp. 645-652
    • Shiffman, M.L.1    Diago, M.2    Tran, A.3
  • 8
    • 0037008087 scopus 로고    scopus 로고
    • Updated definitions of healthy ranges for serum alanine aminotransferase levels
    • Prati D, Taioli E, Zanella A etal. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002; 137: 1-10.
    • (2002) Ann Intern Med , vol.137 , pp. 1-10
    • Prati, D.1    Taioli, E.2    Zanella, A.3
  • 9
    • 0037126675 scopus 로고    scopus 로고
    • Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection
    • Alberti A, Noventa F, Benvegnu L, Boccato S, Gatta A. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med 2002; 137: 961-4.
    • (2002) Ann Intern Med , vol.137 , pp. 961-964
    • Alberti, A.1    Noventa, F.2    Benvegnu, L.3    Boccato, S.4    Gatta, A.5
  • 10
    • 0000427157 scopus 로고    scopus 로고
    • Treatment in patients with normal ALT levels. EASL International Consensus Conference on Hepatitis C: Consensus Statement
    • Tassopoulos NC. Treatment in patients with normal ALT levels. EASL International Consensus Conference on Hepatitis C: Consensus Statement. J Hepatol 1999; 30: 956-61.
    • (1999) J Hepatol , vol.30 , pp. 956-961
    • Tassopoulos, N.C.1
  • 11
    • 0030955348 scopus 로고    scopus 로고
    • Therapy of hepatitis C: patients with normal aminotransferase levels. National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C
    • Marcellin P, Levy S, Erlinger S. Therapy of hepatitis C: patients with normal aminotransferase levels. National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C. Hepatology 1997; 26: 133S-6S.
    • (1997) Hepatology , vol.26
    • Marcellin, P.1    Levy, S.2    Erlinger, S.3
  • 12
    • 65449136656 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C: an update
    • Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009; 49: 1335-74.
    • (2009) Hepatology , vol.49 , pp. 1335-1374
    • Ghany, M.G.1    Strader, D.B.2    Thomas, D.L.3    Seeff, L.B.4
  • 13
    • 0035991459 scopus 로고    scopus 로고
    • Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC)
    • Puoti C, Castellacci R, Montagnese F etal. Histological and virological features and follow-up of hepatitis C virus carriers with normal aminotransferase levels: the Italian prospective study of the asymptomatic C carriers (ISACC). J Hepatol 2002; 37: 117-23.
    • (2002) J Hepatol , vol.37 , pp. 117-123
    • Puoti, C.1    Castellacci, R.2    Montagnese, F.3
  • 14
    • 0037126675 scopus 로고    scopus 로고
    • Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection
    • Alberti A, Noventa F, Benvegnù L, Boccato S, Gatta A. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med 2002; 137: 961-4.
    • (2002) Ann Intern Med , vol.137 , pp. 961-964
    • Alberti, A.1    Noventa, F.2    Benvegnù, L.3    Boccato, S.4    Gatta, A.5
  • 15
    • 0030670088 scopus 로고    scopus 로고
    • Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels
    • Puoti C, Magrini A, Stati T etal. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Hepatology 1997; 26: 1393-8.
    • (1997) Hepatology , vol.26 , pp. 1393-1398
    • Puoti, C.1    Magrini, A.2    Stati, T.3
  • 16
    • 9644262441 scopus 로고    scopus 로고
    • Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels
    • Zeuzem S, Diago M, Gane E etal. Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 2004; 127: 1724-32.
    • (2004) Gastroenterology , vol.127 , pp. 1724-1732
    • Zeuzem, S.1    Diago, M.2    Gane, E.3
  • 17
    • 73349108458 scopus 로고    scopus 로고
    • Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study
    • Puoti C, Pellicelli AM, Romano M etal. Treatment of hepatitis C virus carriers with persistently normal alanine aminotransferase levels with peginterferon alpha-2a and ribavirin: a multicentric study. Liver Int 2009; 29: 1479-84.
    • (2009) Liver Int , vol.29 , pp. 1479-1484
    • Puoti, C.1    Pellicelli, A.M.2    Romano, M.3
  • 18
    • 72949119342 scopus 로고    scopus 로고
    • Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France
    • Deuffic-Burban S, Babany G, Lonjon-Domanec I etal. Impact of pegylated interferon and ribavirin on morbidity and mortality in patients with chronic hepatitis C and normal aminotransferases in France. Hepatology 2009; 50: 1351-9.
    • (2009) Hepatology , vol.50 , pp. 1351-1359
    • Deuffic-Burban, S.1    Babany, G.2    Lonjon-Domanec, I.3
  • 19
    • 0037179698 scopus 로고    scopus 로고
    • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
    • Fried MW, Shiffman ML, Reddy KR etal. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-82.
    • (2002) N Engl J Med , vol.347 , pp. 975-982
    • Fried, M.W.1    Shiffman, M.L.2    Reddy, K.R.3
  • 20
    • 0035934568 scopus 로고    scopus 로고
    • Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    • Manns MP, McHutchison JG, Gordon SC etal. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65.
    • (2001) Lancet , vol.358 , pp. 958-965
    • Manns, M.P.1    McHutchison, J.G.2    Gordon, S.C.3
  • 21
    • 78649487476 scopus 로고    scopus 로고
    • Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C
    • Pattullo V, Heathcote EJ, Wong DK. Superior response to pegylated interferon and ribavirin in Asians with chronic hepatitis C. Hepatol Int 2010; 4: 723-31.
    • (2010) Hepatol Int , vol.4 , pp. 723-731
    • Pattullo, V.1    Heathcote, E.J.2    Wong, D.K.3
  • 22
    • 33644889900 scopus 로고    scopus 로고
    • Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group
    • Furusyo N, Katoh M, Tanabe Y etal. Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group. World J Gastroenterol 2006; 12: 784-90.
    • (2006) World J Gastroenterol , vol.12 , pp. 784-790
    • Furusyo, N.1    Katoh, M.2    Tanabe, Y.3
  • 23
    • 47649095345 scopus 로고    scopus 로고
    • Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group
    • Furusyo N, Kajiwara E, Takahashi K etal. Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group. J Gastroenterol Hepatol 2008; 23: 1094-104.
    • (2008) J Gastroenterol Hepatol , vol.23 , pp. 1094-1104
    • Furusyo, N.1    Kajiwara, E.2    Takahashi, K.3
  • 24
    • 35548933202 scopus 로고    scopus 로고
    • Detection and quantitation of HCV RNA using real-time PCR after automated sample processing
    • Sandres-Sauné K, Abravanel F, Nicot F etal. Detection and quantitation of HCV RNA using real-time PCR after automated sample processing. J Med Virol 2007; 79: 1821-6.
    • (2007) J Med Virol , vol.79 , pp. 1821-1826
    • Sandres-Sauné, K.1    Abravanel, F.2    Nicot, F.3
  • 25
    • 33947133809 scopus 로고    scopus 로고
    • Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system
    • Sizmann D, Boeck C, Boelter J etal. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol 2007; 38: 326-33.
    • (2007) J Clin Virol , vol.38 , pp. 326-333
    • Sizmann, D.1    Boeck, C.2    Boelter, J.3
  • 26
    • 79954620612 scopus 로고    scopus 로고
    • Ribavirin concentration in the later stages of 48week pegylated interferon-α2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response
    • Furusyo N, Murata M, Ogawa E etal. Ribavirin concentration in the later stages of 48week pegylated interferon-α2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response. J Antimicrob Chemother 2011; 66: 1127-39.
    • (2011) J Antimicrob Chemother , vol.66 , pp. 1127-1139
    • Furusyo, N.1    Murata, M.2    Ogawa, E.3
  • 27
    • 68749109781 scopus 로고    scopus 로고
    • Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin
    • Hiramatsu N, Oze T, Yakushijin T etal. Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin. J Viral Hepat 2009; 16: 586-94.
    • (2009) J Viral Hepat , vol.16 , pp. 586-594
    • Hiramatsu, N.1    Oze, T.2    Yakushijin, T.3
  • 28
    • 77957585975 scopus 로고    scopus 로고
    • Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C
    • Kainuma M, Furusyo N, Kajiwara E etal. Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C. World J Gastroenterol 2010; 16: 4400-9.
    • (2010) World J Gastroenterol , vol.16 , pp. 4400-4409
    • Kainuma, M.1    Furusyo, N.2    Kajiwara, E.3
  • 29
    • 36549058800 scopus 로고    scopus 로고
    • Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
    • Okanoue T, Itoh Y, Minami M etal. Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts. Hepatol Res 2008; 38: 27-36.
    • (2008) Hepatol Res , vol.38 , pp. 27-36
    • Okanoue, T.1    Itoh, Y.2    Minami, M.3
  • 30
    • 77951701962 scopus 로고    scopus 로고
    • Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection
    • Hsu CS, Liu CH, Liu CJ etal. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection. J Gastroenterol Hepatol 2010; 25: 970-7.
    • (2010) J Gastroenterol Hepatol , vol.25 , pp. 970-977
    • Hsu, C.S.1    Liu, C.H.2    Liu, C.J.3
  • 31
    • 79952651309 scopus 로고    scopus 로고
    • Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort
    • Ramcharran D, Wahed AS, Conjeevaram HS etal. Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort. J Viral Hepat 2011; 18: 144-52.
    • (2011) J Viral Hepat , vol.18 , pp. 144-152
    • Ramcharran, D.1    Wahed, A.S.2    Conjeevaram, H.S.3
  • 32
    • 0031891214 scopus 로고    scopus 로고
    • Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study
    • Sangiovanni A, Morales R, Spinzi G etal. Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels: a pilot randomized controlled study. Hepatology 1998; 27: 853-6.
    • (1998) Hepatology , vol.27 , pp. 853-856
    • Sangiovanni, A.1    Morales, R.2    Spinzi, G.3
  • 33
    • 0033659668 scopus 로고    scopus 로고
    • Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients?
    • Puoti C, Castellacci R, Montagnese F. Hepatitis C virus carriers with persistently normal aminotransferase levels: healthy people or true patients? Dig Liver Dis 2000; 32: 634-43.
    • (2000) Dig Liver Dis , vol.32 , pp. 634-643
    • Puoti, C.1    Castellacci, R.2    Montagnese, F.3
  • 34
    • 0033731762 scopus 로고    scopus 로고
    • Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels
    • Ohmiya M, Hayashi J, Ueno K etal. Effectiveness of interferon treatment for patients with chronic hepatitis C virus infection and normal aminotransferase levels. Dig Dis Sci 2000; 45: 1953-8.
    • (2000) Dig Dis Sci , vol.45 , pp. 1953-1958
    • Ohmiya, M.1    Hayashi, J.2    Ueno, K.3
  • 35
    • 72949123800 scopus 로고    scopus 로고
    • Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease?
    • Lawson A. Hepatitis C virus-infected patients with a persistently normal alanine aminotransferase: do they exist and is this really a group with mild disease? J Viral Hepat 2010; 17: 51-8.
    • (2010) J Viral Hepat , vol.17 , pp. 51-58
    • Lawson, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.